Studies in animals, including a model of arthritis, as well as in patients with psoriatic arthritis and lupus, have shown that, in addition to improving insulin sensitivity, thiazolidinediones decrease inflammation[19-28]. This evidence concerns the gene INS and psoriatic arthritis.